Performance Highlights - Q2 FY27

  • Revenue: ₹20,321 million (US$212.6M), representing 22.5% YoY growth and 12.2% constant currency growth
  • Adjusted EBITDA: ₹5,353 million (US$56.0M) at 26.3% margin, showing 23.0% YoY growth
  • Adjusted PAT: ₹3,254 million (US$34.0M) at 16.0% margin, with 8.1% YoY growth
  • Organic constant currency growth (excluding CareSeed): 11.9% YoY

Performance Highlights - H1 FY27

  • Revenue: ₹39,956 million (US$420.4M), representing 25.0% YoY growth and 13.7% constant currency growth
  • Adjusted EBITDA: ₹10,069 million (US$105.9M) at 25.2% margin, showing 25.2% YoY growth
  • Adjusted PAT: ₹5,951 million (US$62.6M) at 14.9% margin, with 18.9% YoY growth
  • Organic constant currency growth (excluding CareSeed): 13.4% YoY

Business Insights & Operational Metrics

  • Won $40.2M of Annual Contract Value (ACV) in Q2 FY27 from 31 existing clients and 1 new logo
  • Growing AI momentum with new SOW wins and production deployments
  • Total employees: 51,486 as of September 30, 2026, representing 16.5% YoY growth
  • Voluntary attrition rate: 25.7% for Q2 FY27 (calculated for employees with tenure exceeding 90 days, annualized)
  • Revenue by vertical: Payer 89.9%, Provider 10.1%
  • DSO (Days Sales Outstanding): 78 days

Acquisition Activity

  • Acquired Chirok Health LLC to accelerate Provider segment growth
  • Chirok Health, founded in 2020 and headquartered in Nashville, provides Clinical Documentation Improvement (CDI) solutions and adjacent services including medical coding, RAC, and HEDIS/Stars quality services
  • Acquisition adds specialized CDI and coding capabilities, extending Sagility's end-to-end RCM offering

Dividend Declaration

  • Interim dividend declared: ₹0.15 per share

Financial Position & Cash Flow

  • Cash and cash equivalents (including investments): ₹10,068 million as of September 30, 2026
  • Operating cash flow: ₹6,343 million for H1 FY27 (64.9% conversion on reported EBITDA)
  • Free cash flow: ₹5,176 million for H1 FY27 (52.9% conversion on reported EBITDA)
  • Debt position: ₹4,255 million as of September 30, 2026 (down from ₹5,776 million as of March 31, 2026)
  • Company plans full debt repayment within current financial year

Balance Sheet Highlights (as of September 30, 2026)

  • Property, plant and equipment: ₹4,644 million
  • Right-of-use assets: ₹4,250 million
  • Goodwill: ₹66,085 million
  • Other intangible assets: ₹20,323 million
  • Trade receivables and unbilled: ₹17,753 million
  • Total equity: ₹102,281 million

Go Forward Positions

  • Debt repayment schedule: ₹5,670 million planned for FY27
  • Share-based payment awards: ₹136 million for FY27, decreasing to ₹74 million in FY28
  • Earnout costs: ₹67 million for FY27 (BroadPath and CareSeed), ₹96 million for FY28 (CareSeed only)
  • Intangibles amortization: ₹1,580 million for FY27 (carve-out related), ₹478 million for FY27 (acquisition related)

Additional Information

  • Presentation available on company website: https://sagility.com/
  • Meeting with investors scheduled for October 22, 2026, at 7:30 p.m. IST
  • Company Secretary & Compliance Officer: Satishkumar Sakharayapattana Seetharamaiah (M. No: A16008)